TTX Clinical Experience

Protocol

Location

Clinical Phase

Indication

Completion Status

MLP-001

China

Phase I

Healthy volunteers

Completed

WEX-US-001

Canada / US

Phase I

Healthy male volunteers

Completed

WEX-001

Canada

Phase I

Healthy volunteers

Completed

WEX-002

Canada

Phase I

Healthy volunteers

Completed

WEX-015

Canada

Phase I

Healthy volunteers

Completed

MLP-002

China

Phase IIa

Cancer patients
(refractory pain)

Completed

WEX-003

Canada

Phase IIa

Cancer patients
(refractory pain)

Completed

WEX-008

Canada

Phase IIa

Cancer patients
(refractory pain)

Completed

WEX-014

Canada

Phase IIb

Cancer patients
(refractory pain)

Completed

WEX-014OL

Canada

Phase IIb

Cancer patients
(refractory pain)

Completed

WEX-016

Canada

Phase II

Non-cancer patients
(intractable non-malignant chronic pain)

Completed

TEC-006

Canada

Phase III

Cancer patients
(refractory pain)

Completed

TEC-006OL

Canada

Phase III

Cancer patients
(refractory pain)

Completed

TTX-CINP-201-PK

United States

Phase I

PK study in Healthy volunteers

Completed

TTX-CINP-201

United States

Phase II

Chemotherapy-induced neuropathic pain

Ongoing